| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,555 |
4,571 |
$11K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
568 |
549 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
903 |
797 |
$189.22 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,887 |
3,306 |
$173.44 |
| 81025 |
|
237 |
218 |
$103.00 |
| 86592 |
|
630 |
623 |
$44.14 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
41 |
41 |
$20.75 |
| 87210 |
|
29 |
24 |
$10.68 |
| 86480 |
|
135 |
133 |
$0.00 |
| 80061 |
Lipid panel |
4,649 |
4,592 |
$0.00 |
| 82540 |
|
614 |
606 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
597 |
537 |
$0.00 |
| 99442 |
|
1,729 |
1,603 |
$0.00 |
| 3077F |
|
210 |
192 |
$0.00 |
| 3078F |
|
769 |
672 |
$0.00 |
| 80076 |
|
2,525 |
2,470 |
$0.00 |
| 82274 |
|
599 |
588 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
266 |
264 |
$0.00 |
| 84439 |
|
131 |
126 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
29 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
214 |
214 |
$0.00 |
| 81003 |
|
126 |
125 |
$0.00 |
| 86703 |
|
1,298 |
1,292 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
214 |
111 |
$0.00 |
| 83540 |
|
264 |
257 |
$0.00 |
| 85610 |
|
187 |
166 |
$0.00 |
| 1033F |
|
95 |
91 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
110 |
106 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 84702 |
|
12 |
12 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
16 |
16 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
15 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,539 |
4,299 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
3,380 |
3,181 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,862 |
2,762 |
$0.00 |
| 83550 |
|
138 |
134 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,102 |
5,045 |
$0.00 |
| 81001 |
|
564 |
544 |
$0.00 |
| 3075F |
|
218 |
210 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
769 |
759 |
$0.00 |
| 85027 |
|
860 |
824 |
$0.00 |
| 2001F |
|
50 |
47 |
$0.00 |
| 1000F |
|
164 |
156 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
8,299 |
7,485 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
591 |
579 |
$0.00 |
| 4450F |
|
75 |
73 |
$0.00 |
| 99443 |
|
2,010 |
1,922 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
302 |
299 |
$0.00 |
| 1220F |
|
701 |
683 |
$0.00 |
| 82607 |
|
157 |
155 |
$0.00 |
| 3080F |
|
145 |
135 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,620 |
1,595 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
280 |
266 |
$0.00 |
| 85008 |
|
99 |
83 |
$0.00 |
| 82043 |
|
614 |
606 |
$0.00 |
| 81000 |
|
163 |
137 |
$0.00 |
| 3074F |
|
778 |
679 |
$0.00 |
| 90656 |
|
49 |
49 |
$0.00 |
| 1111F |
|
367 |
343 |
$0.00 |
| 90686 |
|
91 |
91 |
$0.00 |
| 3079F |
|
295 |
276 |
$0.00 |
| 88187 |
|
389 |
386 |
$0.00 |
| 83735 |
|
28 |
27 |
$0.00 |
| 82728 |
|
110 |
105 |
$0.00 |
| 86780 |
|
787 |
782 |
$0.00 |
| 87340 |
|
112 |
110 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
266 |
264 |
$0.00 |
| 85652 |
|
76 |
74 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
122 |
119 |
$0.00 |
| 3044F |
|
489 |
485 |
$0.00 |
| 87088 |
|
210 |
205 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$0.00 |
| 99441 |
|
106 |
105 |
$0.00 |
| 86141 |
|
12 |
12 |
$0.00 |
| 92227 |
|
13 |
13 |
$0.00 |
| 86706 |
|
63 |
62 |
$0.00 |
| 87205 |
|
12 |
12 |
$0.00 |
| 87536 |
|
14 |
13 |
$0.00 |
| 84703 |
|
15 |
14 |
$0.00 |
| 80422 |
|
34 |
32 |
$0.00 |